Journal Guide

The Lancet is the world's leading independent general medical journal. The journal's coverage is international in focus and extends to all aspects of human health.The Lancet publishes the original primary research and review articles of the highest standard. The Lancet is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Drawing on an international network of advisers and contributors, The Lancet meets the needs of physicians by adding to their clinical knowledge and alerting them to current issues affecting the practice of medicine worldwide. The blend of challenging editorials, signed commentaries, original research, commissioned reviews, an international news section, and the views of readers in the letters pages make The Lancet an essential weekly read for physicians all over the world.The Lancet has an impact factor of 39.060. The journal is currently ranked second out of 153 journals in the general medicine category (2012 Journal Citation Reports, © Thomson Reuters 2013).Visit The Lancet's website at www.TheLancet.com to find out more.

The Lancet Child & Adolescent Health publishes any original research or evidence-based review that will directly impact clinical practice or child health across the disciplines of general paediatrics, adolescent medicine, child development, or any paediatric subspecialty. The journal will consider any contribution that advocates change in, or illuminates, clinical practice in these particular areas.

The journal publishes a range of article types including Articles, Reviews, Viewpoints, Clinical Pictures, Comments, and Correspondence. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. All original research judged eligible for consideration by the journal’s editors will be entered into our fast-track peer-review process, and if accepted, will be published within 8 weeks from submission.

Further details on the different sections of The Lancet Child & Adolescent Health, and how to submit to the journal, are provided below. If you require further clarification, the journal’s editorial staff will be pleased to help (email child-adolescent@lancet.com).

The Lancet Diabetes & Endocrinology, dedicated to covering the disciplines of diabetes, endocrinology, and metabolism, is the latest title in The Lancet family of specialty journals. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Diabetes & Endocrinology will contain Original Research, Reviews, Comments, and News.The Lancet Diabetes & Endocrinology is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks on average of submission and published Online First on TheLancet.com before the print issue.Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at thelancet.com.The journal is now accepting submissions of Original Research, Review, and Personal Views. Visit http://ees.elsevier.com/thelancetde to learn more about our editorial scope and aims and to submit your manuscript.To find out more about The Lancet Diabetes & Endocrinology, visit http://www.TheLancet.com/diabetes-endocrinology

The Lancet Digital Health is a gold Open Access journal in the Lancet family of journals. Building on The Lancet's tradition as an advocate for health, this new monthly journal is committed to publishing high-quality original research, comment, and correspondence contributing to promoting digital technologies in health practice worldwide. By bringing together the most important advances in this multidisciplinary field, The Lancet Digital Health aspires to be the most prominent publishing venue in digital health.

The Lancet Digital Health publishes important, innovative, and practice-changing research on any topic connected with digital technology in clinical medicine, public health, and global health. The Lancet Digital Health's content crosses subject boundaries, building bridges between health professionals and researchers.

The Lancet Gastroenterology & Hepatology launched in September, 2016, and is a monthly journal of original research, review, opinion, and news covering international issues relevant to gastroenterologists and hepatologists worldwide.

Launched in June, 2013, The Lancet Global Health is a new open access, online title from The Lancet. This exciting new journal is dedicated to publishing high-quality original research, commentary, correspondence, and blogs on the following subjects as they pertain to low- and middle-income countries: reproductive, maternal, neonatal, and child health; adolescent health; infectious diseases, including neglected tropical diseases; non-communicable diseases; mental health; the global health workforce; health systems; health policy; and public health. All original research is subjected to The Lancet's usual rigorous standards of external clinical and statistical peer review, and will be edited by experienced copy editors to the highest standards.Visit http://www.lancet.com/langlo/launch for more information.

The Lancet HIV launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence. The monthly journal provides readers with context and insight into the clinical advances and practice-changing research shaping the study of HIV/AIDS today.

Now is a critical moment in the fight against HIV/AIDS. Despite the world view that the end of AIDS may be within reach, the job of controlling this epidemic is certainly not done. As HIV disease evolves to become a chronic infection, the interaction of the virus with other chronic conditions will present a host of new challenges.The Lancet HIV is a journal for a new era in the history of HIV/AIDS.

The Lancet HIV builds onThe Lancet journals' reputation for publishing HIV/AIDS research to provide a reliable foundation for advocacy and for programmatic and political change. We will consider clinical, epidemiological, operational, and implementation research, unifying these disciplines across a single vision for the health of those living with HIV.

Following inThe Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical HIV/AIDS community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.

Visit http://www.thelancet.com/hiv for more information.

The Lancet Haematology launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence that advocate a change in, or illuminate, haematological clinical practice.

The Lancet Haematology builds onThe Lancet journals' reputation for publishing high-impact research and covers the breadth of clinical haematology which includes, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine.

Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research.

Visit http://www.thelancet.com/haematology for more information.

The Lancet Healthy Longevity is an open-access, multi-disciplinary journal that publishes clinically-focussed longevity and healthy ageing research and review. The broad research remit aims to encompass early-stage clinical research into the mechanisms of ageing through to epidemiological and societal research on changing populations, including clinical trials in all disciplines focussed on older people, gerontological science, and age-specific clinical guidelines. We will also publish clinical and policy reviews which aim to shape and contextualise the debate on this fast-growing discipline. The Lancet Healthy Longevity will continue in the Lancet family tradition of being a strong advocate for the rights of all people to healthy, fulfilling lives, irrespective of age, and prioritises reports of original research that are likely to change clinical practice or thinking.

The Lancet Infectious Diseases is recognized for providing a global, authoritative, and independent forum for the highest quality infectious diseases research and opinion, covering the research and treatment of diseases and conditions such as HIV/AIDS, healthcare association infections, antibiotic resistance, malaria, tuberculosis, emerging infections, and public health. The Lancet Infectious Diseases publishes original research, reviews, personal views, commentaries, and news across the global field of infectious diseases. The journal is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is fast-tracked to publication within 8 weeks on average of submission and published first online on TheLancet.com before the print issue.

The Lancet Microbe publishes original research, review, and personal views on clinically relevant microbes at all scales—from the nature of the microbe (eg, antimicrobial resistance genes/plasmids, virulence factors) to the microbiome, to pathology (including immunology) to population level effects (eg, outbreaks, epidemiology). Furthermore, it includes early phase clinical trials and other interventional studies where the outcomes are focused on the pathogen. Lancet Microbe provides a destination for the best microbiology-focused clinical research and review. All submissions are handled in the rigorous manner expected of any journal within the Lancet family. Also in keeping with the Lancet ethos, Lancet Microbe is a strong advocate for and collaborator with the microbial research community.

The Lancet Neurology is recognized for providing a global, authoritative, and independent forum for the highest quality clinical neurology research, reviews, and news covering all areas of global clinical neurology with a particular focus in the research and treatment of stroke, multiple sclerosis, movement disorders, epilepsy, dementia, and headache.The Lancet Neurology publishes original research, reviews, personal views, commentaries, and news across the global field of clinical neurology. The journal is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. All original research is fast-tracked to publication within 8 weeks of submission and published first online on TheLancet.com before the print issue.With an impact factor of 23.917*, the journal ranks highest among the world's leading clinical neurology journals and has maintained this leading position in the Journal Citation Reports® since 2004.Visit www.TheLancet.com to find out more about The Lancet Neurology.* 2012 Journal Citation Reports, Thomson Reuters© 2013.